Deixe a Mitral vazar, leve a moderadamente.

  • 1A
  • After a randomized trial showed no clinical benefit of mitral valve repair among patients with chronic, moderate ischemic MR undergoing coronary artery bypass grafting, the LOE was changed from C (consensus) to B-R (moderate quality evidence from ≥1 randomized controlled trial [RCT] or meta-analyses of moderate-quality RCT) for the Class IIb recommendation for mitral valve repair in this population.



É emocionante ouvir um cirurgião cardíaco descrever o reparo da valva Mitral .

Parece mágico.

Mas não é.



Deixe uma resposta